Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for In-Line Weight Monitoring during Compression – V 2.0

Posted on By

Tablets: SOP for In-Line Weight Monitoring during Compression – V 2.0

Standard Operating Procedure for In-Line Weight Monitoring during Compression

Department Tablet
SOP No. SOP/TAB/070/2025
Supersedes SOP/TAB/070/2022
Page No. Page 1 of 6
Issue Date 30/01/2026
Effective Date 04/02/2026
Review Date 30/01/2027

1. Purpose

To outline the procedure for in-line weight monitoring during tablet compression, ensuring that tablets meet the specified weight requirements during the manufacturing process.

2. Scope

This SOP applies to the use of in-line weight monitoring systems during the compression phase of tablet manufacturing to ensure weight uniformity across all tablets in the batch.

3. Responsibilities

  • Manufacturing Personnel: Responsible for operating the tablet press, ensuring the in-line weight monitoring system is functioning correctly, and adjusting parameters as necessary.
  • Quality Control (QC): Responsible for monitoring the weight distribution of the tablets during the compression process and ensuring that they meet the specified weight tolerances.
  • Quality Assurance (QA): Ensures compliance with this SOP and reviews the records for approval of the final batch.
  • Maintenance Personnel: Responsible for ensuring that the in-line weight monitoring system is calibrated, maintained, and functioning properly.

4. Accountability

The Production Manager is accountable for ensuring that the in-line weight monitoring system is set up and used according to this SOP. The QA Manager is responsible for approving the final batch after reviewing weight distribution records.

See also  Tablets: SOP for Ensuring Compliance with Regulatory Guidelines - V 2.0

5. Procedure

5.1 Pre-Compression Setup

  1. Ensure the tablet press is set up with the appropriate tooling for the batch size.
  2. Calibrate the in-line weight monitoring system according to the manufacturer’s specifications to ensure accurate measurements.
  3. Verify that the in-line weight monitoring system is properly integrated with the tablet press and that it is correctly measuring the weight of the tablets during compression.
  4. Set the acceptable weight limits as per the batch record, ensuring the upper and lower tolerance levels are established.

5.2 Weight Monitoring during Compression

  1. Start the compression process and monitor the weight of tablets continuously via the in-line monitoring system.
  2. Ensure that the system is recording the weight of each tablet, providing real-time data on the tablet weight during the compression process.
  3. Regularly check the data from the weight monitoring system to ensure that the tablets fall within the established weight tolerance limits.
  4. If any tablet weight exceeds or falls below the specified limits, adjust the compression force or other relevant parameters to bring the weight back within specifications.
  5. Ensure that any adjustments are made promptly to prevent further deviations from the target tablet weight.

5.3 Handling Weight Deviation

  1. If tablets fall outside of the weight tolerance range, investigate the cause of the deviation. Potential causes could include incorrect tooling, incorrect material properties, or improper compression force.
  2. Document any deviations in the deviation report (Annexure-1) and take corrective actions such as adjusting the tooling, re-calibrating the weight monitoring system, or altering compression settings.
  3. If deviations persist, halt production and investigate further to identify and resolve the root cause of the issue.
  4. Sample tablets periodically for manual weighing and ensure that the weight data matches the in-line weight monitoring system readings.
See also  Tablets: SOP for Moisture Control During Granule Drying - V 2.0

5.4 Post-Compression Weight Inspection

  1. After compression, perform a final inspection of a sample of tablets to verify that they meet the required weight specifications.
  2. Verify the average tablet weight and ensure that it falls within the established specifications in the batch record.
  3. If the average weight does not meet the specified requirements, investigate the cause and document the findings in the deviation report (Annexure-1).

5.5 Documentation and Record-Keeping

  1. Document all weight monitoring results, including the real-time weight data from the in-line monitoring system and manual weight checks, in the batch record (Annexure-2).
  2. Record any deviations from the specified weight limits and corrective actions taken in the deviation report (Annexure-1).
  3. Ensure that all records are signed, dated, and retained according to the company’s record retention policy.

5.6 Calibration and Maintenance of Weight Monitoring System

  1. Ensure that the in-line weight monitoring system is regularly calibrated according to the manufacturer’s recommendations.
  2. Perform routine maintenance on the system, including cleaning and checking for wear and tear on components such as sensors and scales.
  3. Document all calibration and maintenance activities in the equipment maintenance log (Annexure-3).
See also  Tablets: SOP for Compression Tooling Inspection and Cleaning - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • API: Active Pharmaceutical Ingredient

7. Documents

  1. Batch Record (Annexure-2)
  2. Deviation Report (Annexure-1)
  3. Equipment Maintenance Log (Annexure-3)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • EU GMP Guidelines Part I – Basic Requirements for Medicinal Products
  • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
15/12/2025 Batch 001 Tablet weight out of specification Adjusted compression force and re-checked weight John Doe

Annexure-2: Batch Record

Batch Number Average Weight Weight Deviation Hardness Comments
Batch 001 250 mg Within specification 7 kg Weight within limits

Annexure-3: Equipment Maintenance Log

Maintenance Date Equipment Maintenance Performed Performed By Comments
05/12/2025 In-Line Weight Monitoring System Calibration and inspection Jane Smith System functioning within specifications

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated Compression Settings Improved Compression Efficiency QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: SOP for Particle Size Analysis in Formulation Screening
Next Post: SOP for Handling Raw Materials Arriving Outside of Working Hours – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version